OBJECTIVE: Detecting and treating elevated intracranial pressure (ICP) is a cornerstone of management in patients with severe traumatic brain injury. The aim of this study was to determine the association between area under the curve measurement of elevated ICP and clinical outcome. METHODS: Single center observational study using prospectively collected data at a University hospital, level one-trauma center. Sixty prospective patients with severe traumatic brain injury were prospectively enrolled over a 2-year period. Intracranial pressure measurements were captured using a real-time automated, high resolution vital signs data recording system. Mortality and functional outcome were assessed at 30 days, 3 and 6 months using Extended Glasgow Outcome Scale. RESULTS: Increasing elevated intracranial pressure time dose was associated with mortality (OR 1.08; 95 % confidence interval [CI], 1.01-1.15, p = 0.03) and poor functional outcome at 3 (OR 1.04; CI 1.00-1.07, p = 0.03) and 6 months (1.04; CI 1.01-1.08, p = 0.02). However, there was no association between episodic ICP data and outcome. CONCLUSIONS: These results suggest that pressure time dose measurement of intracranial pressure may be used to predict outcome in severe traumatic brain injury and may be a candidate biomarker in this disease.
OBJECTIVE: Detecting and treating elevated intracranial pressure (ICP) is a cornerstone of management in patients with severe traumatic brain injury. The aim of this study was to determine the association between area under the curve measurement of elevated ICP and clinical outcome. METHODS: Single center observational study using prospectively collected data at a University hospital, level one-trauma center. Sixty prospective patients with severe traumatic brain injury were prospectively enrolled over a 2-year period. Intracranial pressure measurements were captured using a real-time automated, high resolution vital signs data recording system. Mortality and functional outcome were assessed at 30 days, 3 and 6 months using Extended Glasgow Outcome Scale. RESULTS: Increasing elevated intracranial pressure time dose was associated with mortality (OR 1.08; 95 % confidence interval [CI], 1.01-1.15, p = 0.03) and poor functional outcome at 3 (OR 1.04; CI 1.00-1.07, p = 0.03) and 6 months (1.04; CI 1.01-1.08, p = 0.02). However, there was no association between episodic ICP data and outcome. CONCLUSIONS: These results suggest that pressure time dose measurement of intracranial pressure may be used to predict outcome in severe traumatic brain injury and may be a candidate biomarker in this disease.
Authors: Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright Journal: J Neurotrauma Date: 2007 Impact factor: 5.269
Authors: Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright Journal: J Neurotrauma Date: 2007 Impact factor: 5.269
Authors: D James Cooper; Jeffrey V Rosenfeld; Lynnette Murray; Yaseen M Arabi; Andrew R Davies; Paul D'Urso; Thomas Kossmann; Jennie Ponsford; Ian Seppelt; Peter Reilly; Rory Wolfe Journal: N Engl J Med Date: 2011-03-25 Impact factor: 91.245
Authors: Deborah M Stein; Megan Brenner; Peter F Hu; Shiming Yang; Erin C Hall; Lynn G Stansbury; Jay Menaker; Thomas M Scalea Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210
Authors: Halinder S Mangat; Xian Wu; Linda M Gerber; Justin T Schwarz; Malik Fakhar; Santosh B Murthy; Philip E Stieg; Jamshid Ghajar; Roger Härtl Journal: Neurosurgery Date: 2020-02-01 Impact factor: 4.654
Authors: M J Rowland; T Veenith; C Scomparin; M H Wilson; P J Hutchinson; A G Kolias; R Lall; S Regan; J Mason; Pjd Andrews; D Horner; J Naisbitt; A Devrell; A Malins; P Dark; D F McAuley; G D Perkins Journal: J Intensive Care Soc Date: 2020-02-25
Authors: Patricia M Washington; Changhee Lee; Mary Kate R Dwyer; Elisa E Konofagou; Steven G Kernie; Barclay Morrison Journal: J Cereb Blood Flow Metab Date: 2019-10-24 Impact factor: 6.200
Authors: B Depreitere; G Citerio; M Smith; P David Adelson; M J Aries; T P Bleck; P Bouzat; R Chesnut; V De Sloovere; M Diringer; J Dureanteau; A Ercole; G Hawryluk; C Hawthorne; R Helbok; S P Klein; J O Neumann; C Robba; L Steiner; N Stocchetti; F S Taccone; A Valadka; S Wolf; F A Zeiler; G Meyfroidt Journal: Neurocrit Care Date: 2021-01-25 Impact factor: 3.210